QT Vascular in US$13.14m convertible debt investment to fund growth
Published Fri, Jul 24, 2015 · 10:53 AM
QT Vascular, a developer of minimally invasive products for the treatment of vascular diseases, has entered into a US$13.14 million convertible debt investment to fund its next growth phase.
This comes less than a month after the company entered into a US$12 million convertible bond investment to further develop its Drug-Coated Chocolate platform.
On Friday, the counter closed down 0.84 per cent, or 0.1 Singapore cent, at S$0.118.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
HSBC says growing Chinese wealth fuels client investments in US
Unilever's India quarterly profit disappoints
US: Wall St opens higher on tech boost, upbeat earnings
GM CEO Barra compensation fell 4% in 2023 to US$27.8 million
Prada’s sales up 16% in first quarter as Miu Miu shines
Boeing reports first revenue drop in 7 quarters as deliveries decline